Search
Displaying 371–380 of 661 for “retinal diseases”
-
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Research NewsOpus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
Research NewsThe company is seeking a partner to move the LCA10 program forward
-
Eye on the Cure Podcast | Episode 33: Jacque Duncan, MD
Eye on the CureOctober 7, 2022. Ben Shaberman talks with Jacque Duncan, MD.
-
SeeShore Fest Fundraiser Success
Beacon StoriesHeather Napolitano started her DIY fundraiser, SeeShore Fest, seven years ago. The event has now raised over $109,000 to fund research finding treatments and cures for blinding diseases.
-
Decades of Dedication Fighting for His Family and Himself
Beacon Stories My Retina Tracker Patient StoriesDan Day is one of over ten people in his family, spanning six generations, affected with retinitis pigmentosa (RP). So to “get off the sidelines and join the fight” for himself and his family, Dan has dedicated over 25 years of service to the Foundation Fighting Blindness.
-
Gene Knock-Out, Replacement Therapy for RP-RHO Performed Well in Lab Study
Research NewsEditas is planning IND-enabling studies of the two-part treatment in preparation for a clinical trial
-
“Great Vision Does Not Require Great Sight”
Beacon StoriesKenyetta has worked to help others through the nonprofit sector for over 25 years, despite being diagnosed with Stargardt disease at the age of 31. Kenyetta is now the chief operating officer of REACH Riverside Development Corporation and has been recognized for her career achievements by many.
-
Research News
The company plans to enroll additional patients as young as four years old
-
Beacon Stories
At seven years old, Hannah had never seen a lightning bug in the summer or a star in the sky. But after her treatment with LUXTURNA, Hannah can now play outside at night with her brothers and has a new bright future in store.
-
Making a stock donation is a powerful way to support the mission of the Foundation Fighting Blindness to drive the research for treatments and cures for blinding diseases affecting 1 in 53 individuals around the world.
%20(1).png)
